Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

ENCORE: Topline Results of a Phase Three Open-label Extension and Randomized-withdrawal Trial of AXS-12 in Narcolepsy

Author:Bogan, Richard   Thorpy, Michael   Krahn, Lois   Corser, Bruce   Shapiro, Colin   Chen, Dan   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:P6: Sleep: Disorders of Excessive Daytime Somnolence  

Topic:Sleep  

Program Number:P6.006  

Author Institution:Medical University of South Carolina, Charleston, SC  Montefiore Medical Center, Sleep-Wake Disorders Center, Bronx, NY  Mayo Clinic College of Medicine, Phoenix, AZ  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Formerly of Axsome Therapeutics, Inc., San Francisco, CA  

Collateral Damage: Immune Checkpoint Inhibitor-induced Myeloneuropathy in a Patient with Merkel Cell Carcinoma

Author:Singh, Simranpreet   Paliwal, Arjun   Shivangi, FNU   Viereck, Matthew   

Session Name:P6: Autoimmune Neurology: Immune Checkpoint Inhibitor and CAR-T 1  

Topic:Autoimmune Neurology  

Program Number:P6.006  

Author Institution:Tower Health Reading Hospital, PA, Reading, PA  Tower Health Reading Hospital, PA, West Reading, PA  

Effectiveness of Cenobamate in Patients with Epileptic Encephalopathies: Analysis of a Single-center Cohort

Author:Sanikommu, Sai   Costas Encarnacion, Yensea   Eatz, Tiffany   MILLAN, CARLOS MAURICIO   Kanner, Andres   

Session Name:P6: Epilepsy/Clinical Neurophysiology (EEG): Retrospective Studies, Systematic Reviews, and Meta-analysis 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P6.006  

Author Institution:University of Miami, Miller School of Medicine, Miami, FL  University of Miami, Miller School of Medicine, Miami Springs, FL  University of Miami Miller School of Medicine, Miami, FL  Baptist Health, Miami, Florida, Fort Lauderdale, FL  University of Miami, Miller School of Medicine, Department of Neurology, Miami, FL